| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 109.99M | 109.99M | 107.16M | 104.82M | 101.80M | 77.91M |
| Gross Profit | 63.23M | 63.23M | 60.03M | 59.73M | 54.56M | 43.94M |
| EBITDA | 15.04M | 17.46M | 15.62M | 17.25M | 18.78M | 13.73M |
| Net Income | 6.51M | 6.51M | 5.79M | 6.69M | 8.49M | 4.05M |
Balance Sheet | ||||||
| Total Assets | 79.24M | 79.24M | 73.97M | 80.25M | 78.97M | 80.08M |
| Cash, Cash Equivalents and Short-Term Investments | 22.31M | 22.31M | 17.76M | 19.75M | 21.79M | 19.34M |
| Total Debt | 26.28M | 26.28M | 23.42M | 26.06M | 27.98M | 30.32M |
| Total Liabilities | 43.95M | 43.95M | 42.23M | 46.29M | 45.83M | 48.98M |
| Stockholders Equity | 35.28M | 35.28M | 31.75M | 33.96M | 33.15M | 31.11M |
Cash Flow | ||||||
| Free Cash Flow | 12.32M | 12.07M | 10.48M | 9.56M | 13.59M | 14.36M |
| Operating Cash Flow | 14.38M | 14.14M | 13.47M | 13.14M | 15.84M | 16.25M |
| Investing Cash Flow | -2.07M | -1.59M | -2.82M | -3.58M | -2.24M | -1.85M |
| Financing Cash Flow | -8.48M | -8.48M | -12.65M | -11.63M | -12.11M | -5.92M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £49.33M | 8.81 | 19.42% | 0.55% | 2.64% | 23.89% | |
74 Outperform | £4.58B | 18.38 | 24.46% | 2.57% | 0.13% | -0.06% | |
68 Neutral | £415.95M | 17.18 | 10.06% | ― | 4.38% | ― | |
68 Neutral | £44.25M | 7.73 | 12.08% | 11.65% | -3.45% | -44.02% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
49 Neutral | £31.80M | -2.07 | -19.58% | 3.45% | -4.23% | -435.86% | |
47 Neutral | £37.72M | -0.83 | -19.28% | ― | -11.65% | -273.57% |
Colefax Group PLC announced a tender offer resulting in the sale of ordinary shares by key executives and directors, including the Chairman and Chief Executive, David Green. The transactions, conducted on the London Stock Exchange, AIM, were part of the company’s strategic financial maneuvers, potentially impacting shareholder value and market perception of the company’s financial health.
The most recent analyst rating on (GB:CFX) stock is a Buy with a £950.00 price target. To see the full list of analyst forecasts on Colefax stock, see the GB:CFX Stock Forecast page.
Colefax Group PLC has successfully completed its Tender Offer, purchasing 691,800 shares, which represents 11.7% of its issued ordinary share capital, at a price of 880 pence per share. This transaction, valued at £6.1 million, will result in the cancellation of the purchased shares, reducing the company’s total voting rights to 5,225,558. The Tender Offer’s completion signifies a strategic move to optimize the company’s capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:CFX) stock is a Buy with a £950.00 price target. To see the full list of analyst forecasts on Colefax stock, see the GB:CFX Stock Forecast page.
Colefax Group PLC has announced a Tender Offer to buy back up to 15% of its issued share capital, with Peel Hunt LLP facilitating the purchase. This strategic move aims to optimize the company’s capital structure and potentially enhance shareholder value by reducing the number of shares in circulation. The Tender Offer, priced at a slight discount to the current market price, allows shareholders to tender their shares, with the company planning to cancel any repurchased shares, thereby reducing its overall share capital.
The most recent analyst rating on (GB:CFX) stock is a Buy with a £950.00 price target. To see the full list of analyst forecasts on Colefax stock, see the GB:CFX Stock Forecast page.